Haas Jason Insider Trades

Insider Trading History

Track insider trading activity for Haas Jason. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $1.56M 6,606 shares
Last Trade
Jun 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$613k 5,783 shares
$105.99
$235.91
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.9k 137,803 shares
$0.21
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $57.4 143,427 shares
Last Trade
Oct 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.6k 18,875 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $55.1 137,803 shares
Last Trade
Oct 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.2k 5,624 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.6k 18,875 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $49.8 124,552 shares
Last Trade
Sep 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$76.2k 45,344 shares
$1.68
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $31.7 79,208 shares
Last Trade
Sep 11, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.5k 19,293 shares
$1.58
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $24 59,915 shares
Last Trade
Sep 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$54.8k 35,363 shares
$1.55
$0.00
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $1.28M 5,444 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$436k 5,444 shares
$80.06
$235.91
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $9.82 24,552 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$24.2k 4,732 shares
$5.12
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $5.58 13,951 shares
Last Trade
Nov 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14k 6,301 shares
$2.22
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $8.1 20,252 shares
Last Trade
Oct 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47k 18,875 shares
$2.49
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $7.55 18,875 shares
Last Trade
Oct 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47k 18,875 shares
$2.49
$0.00
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $1.29M 5,461 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 5,461 shares
$73.76
$235.91
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $0.551 1,377 shares
Last Trade
Apr 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.61k 623 shares
$2.58
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $2.4 6,000 shares
Last Trade
Mar 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34k 2,000 shares
$2.67
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $0.8 2,000 shares
Last Trade
Mar 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34k 2,000 shares
$2.67
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $16 40,000 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$161k 40,000 shares
$4.02
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Financial Officer
Holding Value $19.9 49,750 shares
Last Trade
Oct 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$589k 87,500 shares
$6.73
$0.00
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $1.39M 5,907 shares
Last Trade
Jun 29, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 5,907 shares
$88.48
$235.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up